Welcome!
Lymphoedema Surgery
Surgical treatment of lymphoedema offers a meaningful reduction in limb swelling, heaviness and recurrent infections (cellulitis) for carefully selected patients. Options include lymphatico-venous anastomosis (LVA) and liposuction-assisted debulking in an evidence-based approach tailored to disease severity and individual anatomy.
My Approach
Lymphoedema surgery is not a cure. It is a carefully planned intervention to reduce disease burden, improve quality of life, and in appropriate patients, reduce dependence on compression garments and manual lymphatic drainage (MLD).
My approach focuses on accurate patient selection, realistic goal-setting, and choosing the right procedure for the right stage of disease. Not every patient with lymphoedema needs surgery, and not every patient who wants surgery is an appropriate candidate.
For patients who have exhausted conservative management or are experiencing progressive disease (such as worsening cellulitis) despite optimal compression therapy, surgical options offer a genuine pathway to improvement.
Planning & Technique
Lymphoedema surgery may be appropriate for patients with:
-
Primary lymphoedema - congenital or idiopathic lymphatic insufficiency causing chronic limb swelling
-
Secondary lymphoedema - most commonly following breast and gynaecological cancer treatment (surgery and/or radiotherapy to lymph nodes) leading to upper and lower limb swelling respectively
Lymphaticovenous Anastomosis (LVA)
LVA is a supermicrosurgical procedure that creates direct connections between functioning lymphatic channels and small veins, allowing lymphatic fluid to bypass areas of obstruction and drain more effectively into the venous system.
It is performed under local anaesthesia or light sedation through small incisions, typically as a day surgery procedure. Indocyanine green (ICG) lymphography is used preoperatively and intraoperatively to map functioning lymphatic channels and identify optimal anastomosis sites.
LVA is most effective in early to moderate-stage lymphoedema where functioning lymphatic channels are still present. It is a low-risk procedure with a well-established evidence base for reducing limb volume and improving symptoms.
Liposuction-Assisted Debulking
In more advanced lymphoedema where chronic protein-rich swelling has led to fibrofatty tissue deposition, LVA alone is insufficient as the excess tissue is no longer fluid but solid. In these cases, liposuction-assisted debulking removes the excess fibrofatty deposits to restore limb contour and proportion.
This is typically combined with ongoing compression garment use postoperatively to maintain results. It is most appropriate for patients with non-pitting lymphoedema and established fibrofatty changes.
A Note on Vascularised Lymph Node Transfer (VLNT)
VLNT involves harvesting lymph nodes from a donor site and transferring them microsurgically to the affected limb. While performed by some centres internationally, I do not routinely offer VLNT. The evidence base remains less robust than for LVA, and there is a recognised risk of inducing lymphoedema at the donor site - a complication I consider unacceptable when safer alternatives exist.
Recovery & Expectations
LVA - day surgery procedure, return to light activity within days. Compression garment use continues postoperatively. Results develop gradually over months as lymphatic flow improves.
Liposuction debulking - day surgery or overnight stay depending on extent. Compression garment use is mandatory postoperatively and long-term. Limb volume reduction is typically immediate but maintenance requires ongoing compliance with compression.
Lymphoedema surgery improves symptoms and reduces disease burden. It does not eliminate the need for ongoing self-management. Patients who are committed to postoperative compression and physiotherapy achieve the best long-term outcomes.
Post-operative care extends beyond routine reviews - it is an integral part of Dr Ng’s surgical philosophy. Through Doctor Stitch, an aftercare service founded to ensure seamless continuity and comfort, every patient is followed up personally by Dr Ng for attentive, discreet, and consistent care throughout the recovery journey.
Frequently Asked Questions
1. Am I a suitable candidate for lymphoedema surgery?
Suitability depends on disease stage, presence of functioning lymphatic channels, and your overall health. A detailed assessment including clinical examination and ICG lymphography is required before any surgical recommendation is made. Not all patients with lymphoedema are surgical candidates.
2. Will surgery cure my lymphoedema?
Surgery reduces disease burden and improves quality of life. It is not a cure. Most patients experience meaningful reduction in limb volume, heaviness, and recurrent infections, with reduced dependence on compression therapy. Ongoing self-management remains important.
3. What is ICG lymphography and will I need it?
Indocyanine green (ICG) lymphography is a minimally invasive imaging technique that maps your lymphatic system using a fluorescent dye. It is essential for planning LVA and is performed as part of your preoperative assessment, as well as during screening (see below).
4. Why don't you offer VLNT?
Vascularised lymph node transfer carries a recognised risk of inducing lymphoedema at the donor site, effectively creating a new problem while attempting to treat the existing one. Given the availability of safer, well-evidenced alternatives such as LVA, I do not consider VLNT an appropriate routine option.
5. How long before I see results from LVA?
LVA results develop gradually over 6-12 months as lymphatic flow improves. Many patients notice early reduction in heaviness and swelling within weeks, with continued improvement over the following months.
6. Do I still need to wear compression garments after surgery?
Yes, particularly after liposuction debulking where long-term compression is essential to maintain results. After LVA, some patients are able to reduce compression garment use over time as lymphatic function improves, but this varies by individual and cannot be guaranteed.
7. What is the lymphedema surveillance programme?
The surveillance programme offers structured monitoring for patients who have undergone lymph node surgery as part of breast or gynaecological cancer treatment. Using ICG lymphography and perometry at regular intervals from 3 months to 3 years post-treatment, it detects subclinical lymphatic changes before symptoms develop, allowing timely LVA intervention when it is most effective. It is available by referral or self-referral.
8. Does it matter how many LVA connections are made during surgery?
The number of lymphovenous anastomoses performed is less important than the quality of the vessels used. A single well-functioning anastomosis using a healthy, patent lymphatic channel is more valuable than multiple connections using poor-quality vessels. This is one of the key reasons the surveillance programme matters - early detection identifies patients while functioning lymphatic channels are still present and of good calibre, maximising the effectiveness of LVA when it is performed.
9. Should lymphedema surgery be performed prophylactically at the time of cancer surgery?
I do not routinely recommend prophylactic lymphatic surgery - for example, performing LVA at the time of axillary lymph node dissection in all patients. The reason is straightforward: approximately 90% of patients who develop early lymphedema following breast cancer treatment will resolve spontaneously without surgical intervention. Performing surgery on all patients to potentially benefit 10% exposes the majority to unnecessary operative time, anaesthetic risk, and potential morbidity.
My approach is to monitor carefully through the surveillance programme and intervene surgically only when there is evidence of persistent, progressive lymphatic dysfunction that is not self-resolving. This ensures that surgery is offered only to patients who genuinely need it, and not as a routine add-on to cancer treatment.
Lymphedema Surveillance Programme
Early detection of lymphedema, before symptoms become established and fibrosis sets in, offers the best chance of successful treatment with minimally invasive surgery such as LVA, rather than requiring more extensive debulking procedures later.
I offer a structured surveillance programme for patients who have undergone axillary or groin lymph node dissection or sentinel node biopsy as part of breast or gynaecological cancer treatment:
Assessment schedule:
-
3 months post-cancer treatment - baseline assessment
-
6 months
-
12 months
-
18 months
-
24 months
-
30 months
-
36 months
Each visit includes:
-
Clinical assessment and symptom review
-
ICG lymphography - real-time mapping of lymphatic flow to detect subclinical changes before they become symptomatic
-
Perometry - objective, reproducible limb volume measurement to track and quantify changes over time
Why does early detection matter?
Lymphedema progresses in stages. In its earliest form, lymphatic dysfunction is present but the limb has not yet undergone fibrofatty changes. At this stage, LVA can be highly effective in redirecting lymphatic flow before irreversible tissue changes occur.
Once fibrosis and fibrofatty deposition have developed, LVA becomes less effective and liposuction for debulking may be required. Early detection and timely intervention avoids this progression.
Who is this programme for?
Any patient who has undergone axillary or inguinal lymph node surgery as part of breast or gynaecological cancer treatment is at risk of developing lymphedema, regardless of whether they have symptoms. The risk is highest in the first 3 years following treatment, which is why surveillance during this window is clinically meaningful.
This programme is available by referral from your breast surgeon or oncologist, or by self-referral.
Related Reading
-
Breast Reconstruction - for patients undergoing or recovering from breast cancer treatment
-
Hand Surgery - for upper limb conditions managed alongside lymphoedema
-
Surgical Treatment of Lymphedema in the Upper Extremity (invited review, Hand Clinics, 2024)
